Literature DB >> 31451324

Contrasts, contradictions and control of cholera.

Sophia Lonappan1, Ria Golecha1, G Balakrish Nair2.   

Abstract

Cholera has been extremely pervasive during the past four decades and continues to remain a significant public health concern. The disease has plagued humankind in the form of seven pandemics since the last two centuries. There is considerable scientific evidence based on research on cholera and its etiologic agent Vibrio cholerae, however we are still unable to accurately forecast and pre-empt the occurrence of cholera outbreaks. The commentary discusses the contrasts and contradictions of cholera, its control and its unpredictable nature. Through a multi-sectoral approach and broad stakeholder collaboration cholera control is possible with meticulous country-level planning for early detection and response to outbreaks. The commentary reiterates that every potential death on account of cholera is preventable because of the available knowledge and tools to effectively prevent and treat cholera.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cholera; Forecast; Global Task Force on Cholera Control; Oral cholera vaccine; Outbreak

Mesh:

Year:  2019        PMID: 31451324     DOI: 10.1016/j.vaccine.2019.08.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Occurrence of Vibrio spp. along the Algerian Mediterranean coast in wild and farmed Sparus aurata and Dicentrarchus labrax.

Authors:  Sonia Arab; Luca Nalbone; Filippo Giarratana; Ali Berbar
Journal:  Vet World       Date:  2020-06-26

2.  Can cholera 'hotspots' be converted to cholera 'coldspots' in cholera endemic countries? The Matlab, Bangladesh experience.

Authors:  K Zaman; Deok Ryun Kim; Mohammad Ali; Faisal Ahmmed; Justin Im; Md Taufiqul Islam; Ashraful Islam Khan; Md Yunus; Md Alfazal Khan; Florian Marks; Firdausi Qadri; Jerome Kim; John D Clemens
Journal:  Int J Infect Dis       Date:  2020-02-29       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.